Invesco Biotechnology & Genome ETF (PBE) is an exchange-traded fund in the Health category. It has $423.52M in assets, an expense ratio of 0.59% and a 1.37% dividend yield. Under normal circumstances, at least 80% of the value of its net assets, plus the amount of any borrowings for investment purposes, in securities of companies engaged in biotechnology- and genome-related industries, and in derivatives and other investments that have economic characteristics similar to securities of companies engaged in biotechnology- and genome-related industries (the “80% investment policy”). It is non-diversified.
Assets under management
$423.52M
Expense ratio
0.59%
Category
Health
Dividend yield
1.37%
NAV
$102.50
Fund family
Invesco
Exchange
NYSE
Top holdings
The largest positions Invesco Biotechnology & Genome ETF reports, by weight.